Developing a molecule, to aim to treat Breast and Pancreatic Cancer.

Transcriptogen Ltd is developing a cancer treatment.  The Company has developed a molecule, TSG1301, which is intended to treat Breast and Pancreatic Cancer tumours.

  • Product

    Life Sciences SEIS
  • Sector

    Cancer treatment
  • Status

    Closed
  • HMRC

    Advanced Assurance